How should I manage a patient who has bruising, a normal prothrombin time (PT), but an elevated international normalized ratio (INR)?

Management of Bruising with Normal PT but Elevated INR

First, verify this is a true laboratory discrepancy rather than a clinical scenario—a "normal PT" with an elevated INR is technically impossible since INR is mathematically derived from the PT, so you likely have a laboratory error, reagent issue, or the patient has a condition affecting INR calculation.

Understanding the Laboratory Discrepancy

The scenario you describe—normal PT with elevated INR—represents a fundamental laboratory inconsistency that requires immediate investigation before any clinical intervention. The INR is calculated directly from the PT using the formula: INR = (Patient PT/MNPT)^ISI, where MNPT is the mean normal PT and ISI is the international sensitivity index 1, 2. Therefore, if the PT is truly normal, the INR must also be normal.

Most Likely Explanations:

Laboratory/Technical Issues:

• Reagent sensitivity problems - Different thromboplastin reagents have varying sensitivities to coagulation factor deficiencies versus anticoagulants 3, 1
• Incorrect ISI or MNPT values assigned to the reagent/instrument combination 2
• Lupus anticoagulant interference - Some recombinant thromboplastins are sensitive to lupus anticoagulants, artificially elevating INR 4
• Pre-analytical errors - Improper sample collection, storage, or processing

Immediate Diagnostic Steps

1. Repeat Testing with Fresh Sample

• Redraw blood using proper technique (citrate tube, correct fill volume)
• Ensure PT and INR are from the same sample and instrument
• Request both PT in seconds and INR to verify mathematical consistency

2. Investigate Patient-Specific Factors

Check for anticoagulant exposure:

• Warfarin or other vitamin K antagonists (even if patient denies, verify medication list)
• Direct oral anticoagulants (DOACs) - particularly anti-Xa agents can interfere with some PT reagents 5
• Heparin contamination from IV lines

Assess for underlying conditions:

• Liver disease - typically shows low Factor V, normal/low fibrinogen, elevated Factor VIII pattern 5, 6
• Vitamin K deficiency - shows low Factor VII, Factor X, Protein C, and Protein S 5
• Lupus anticoagulant - can cause reagent-specific INR elevation without true PT prolongation 4

3. Laboratory Investigation Protocol

If discrepancy persists on repeat testing:

Order specific factor assays:

• Factor VII (most sensitive to vitamin K deficiency and correlates inversely with INR, r = -0.81) 5
• Factor X (also correlates with INR, r = -0.67) 5
• Factor V (does NOT correlate with INR in isolation, r = -0.04) 5
• Fibrinogen

Pattern recognition:

• Vitamin K deficiency pattern: Low FVII, FX, Protein C, Protein S 5
• Liver disease pattern: Low FV, normal/low fibrinogen, high FVIII 5
• Anticoagulant effect: Check anti-Xa level (>0.01 IU/mL suggests DOAC) 5

Test for lupus anticoagulant:

• Mixing study
• Lupus anticoagulant panel
• Consider testing with different thromboplastin reagent 4

Management Based on Findings

If Warfarin Effect Confirmed (True Elevated INR):

For bruising without major bleeding and INR <5:

• Hold 1-2 doses of warfarin
• Resume at lower dose when INR approaches therapeutic range 7

For bruising with INR 5-9 and increased bleeding risk:

• Omit warfarin AND give oral vitamin K 1-2.5 mg 7
• Oral route is preferred over subcutaneous (unpredictable absorption) or IV (anaphylaxis risk) 7
• Recheck INR in 24 hours; 95% will have lower INR, 85% will be <4 7

For INR ≥9 without major bleeding:

• Give oral vitamin K 3-5 mg 7, 8
• Expect INR reduction within 24-48 hours 8
• Monitor closely and repeat vitamin K as needed

If Vitamin K Deficiency (Non-Warfarin):

• Administer vitamin K 1-2.5 mg orally for correction
• Investigate underlying cause (malnutrition, malabsorption, antibiotic use)
• No need for plasma transfusion 5

If Liver Disease:

• Do NOT give plasma prophylactically for elevated INR alone 5
• INR in liver disease reflects different pathophysiology than warfarin effect 6
• Plasma transfusion is inappropriate and ineffective for "correcting" liver disease INR 5
• Manage bleeding risk based on clinical assessment, not INR value

If Laboratory Error/Lupus Anticoagulant:

• Request testing with alternative thromboplastin reagent less sensitive to lupus anticoagulant 4
• Document baseline INR for future anticoagulation monitoring if needed
• No specific treatment required for isolated laboratory finding

Critical Pitfalls to Avoid

Do not transfuse plasma based on INR alone - This is particularly important in ICU settings where elevated INR is common but often due to vitamin K deficiency (correctable with vitamin K) or liver disease (where plasma is inappropriate) 5

Do not use high-dose vitamin K (10 mg) for non-emergent situations - This can cause warfarin resistance for up to one week 7

Do not assume all elevated INRs represent the same pathophysiology - The mechanisms differ significantly between warfarin effect, liver disease, and vitamin K deficiency 5, 6

Do not ignore the mathematical impossibility - A truly normal PT cannot produce an elevated INR; investigate the laboratory discrepancy first before treating the patient 3, 1, 2